Key Summary
- MHRA reported that Ramipril 2.5mg capsules are recalled after packaging errors.
- It is manufactured by Crescent Pharma Limited.
- The MHRA has advised patients to seek medical help if they have the affected batch and are experiencing side effects.
The Medicines and Healthcare products Regulatory Agency (MHRA) has reported that Crescent Pharma Limited’s blood pressure medication, Ramipril 2.5mg capsules, has been recalled after a packaging error.
Patients taking the capsules have been advised to check their packaging for batch number GR155023 and contact their pharmacy if any blister strips inside are labelled as Ramipril 10mg.
Crescent Pharma Limited is issuing a precautionary recall for one batch of its Ramipril 2.5mg capsules due to a packaging mix-up.
The recall was triggered after a healthcare professional found a sealed 2.5mg carton containing two blister strips of Ramipril 10mg capsules instead.
Both dosages were manufactured at the same site, and the error appears to have occurred during the secondary packaging process.
MHRA chief safety officer Dr Alison Cave said, “If you have an affected pack or previously received this batch and you believe you have taken any Ramipril 10mg capsules that were included in error and are currently experiencing any side effects, please seek medical advice.”
Patients accidentally taking the higher dose may experience side effects such as lightheadedness, fainting, fatigue, or altered kidney function.
Patients with the affected batch should take their remaining tablets and the medicine's informational leaflet to their pharmacy or GP practise.
Healthcare and pharmacy professionals have been instructed to immediately stop supplying batch GR155023, quarantine it, and return all stock to suppliers.
